Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
34 hedge funds and large institutions have $2.07M invested in Neurotrope, Inc. Common in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
10% more funds holding
Funds holding: 31 → 34 (+3)
2% more capital invested
Capital invested by funds: $2.03M → $2.07M (+$40.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$107K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$39.5K |
| 3 |
VF
Virtu Financial
New York
|
+$34.5K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$28.8K |
| 5 |
Two Sigma Investments
New York
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
-$89K |
| 2 |
Squarepoint
New York
|
-$58K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.6K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.49K |
| 5 |
BlackRock
New York
|
-$1.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Federated Hermes
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
CG
27
Cutler Group
San Francisco,
California
| $2K | +$575 | +500 | +29% |
|
|
CCM
28
Chiron Capital Management
Tallahassee,
Florida
| $2K | +$1.73K | +1,500 | New |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
MA
30
MYDA Advisors
Woodmere,
New York
| – | -$89K | -76,909 | Closed |
|
|
31
Squarepoint
New York
| – | -$58K | -50,334 | Closed |
|
|
TI
32
tru Independence
Portland,
Oregon
| – | -$2 | -1,500 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | -$460 | -400 | -94% |
|
34
Wells Fargo
San Francisco,
California
| – | +$70 | +61 | +91% |
|
NTRP Hedge Fund Activity: Q3 2020 in Review
34 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q3 2020, worth a combined $2.07M — up 2% from $2.03M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NTRP positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $107K. The largest seller was MYDA Advisors, exiting entirely with an estimated $89K sold.
- 34 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q3 2020, up from 31 in Q2 2020.
- Funds reported $2.07M of Neurotrope, Inc. Common stock for Q3 2020, up 2% quarter-over-quarter.
- 6 funds opened new Neurotrope, Inc. Common positions in Q3 2020 and 3 closed out, a net change of +3 holders.
- The largest Neurotrope, Inc. Common buyer in Q3 2020 was Renaissance Technologies, an estimated $107K added.
- The largest Neurotrope, Inc. Common seller in Q3 2020 was MYDA Advisors, an estimated $89K sold.
Based on aggregated 13F filings for Q3 2020.